These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Resistance to inhibitors of the human immunodeficiency virus type 1 integration. Hazuda DJ Braz J Infect Dis; 2010; 14(5):513-8. PubMed ID: 21221483 [TBL] [Abstract][Full Text] [Related]
24. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore. Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294 [TBL] [Abstract][Full Text] [Related]
25. Development of resistance against diketo derivatives of human immunodeficiency virus type 1 by progressive accumulation of integrase mutations. Fikkert V; Van Maele B; Vercammen J; Hantson A; Van Remoortel B; Michiels M; Gurnari C; Pannecouque C; De Maeyer M; Engelborghs Y; De Clercq E; Debyser Z; Witvrouw M J Virol; 2003 Nov; 77(21):11459-70. PubMed ID: 14557631 [TBL] [Abstract][Full Text] [Related]
26. Inhibitors of HIV-1 entry and integration: recent developments and impact on treatment. Sharma AK; George V; Valiathan R; Pilakka-Kanthikeel S; Pallikkuth S Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):151-61. PubMed ID: 23578097 [TBL] [Abstract][Full Text] [Related]
27. HIV integrase as a target for antiviral chemotherapy. Nair V Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143 [TBL] [Abstract][Full Text] [Related]
28. HIV-1 integrase: a target for new AIDS chemotherapeutics. Anthony NJ Curr Top Med Chem; 2004; 4(9):979-90. PubMed ID: 15134552 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors. Meadows DC; Mathews TB; North TW; Hadd MJ; Kuo CL; Neamati N; Gervay-Hague J J Med Chem; 2005 Jul; 48(14):4526-34. PubMed ID: 15999991 [TBL] [Abstract][Full Text] [Related]
31. L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro. Reinke RA; Lee DJ; McDougall BR; King PJ; Victoria J; Mao Y; Lei X; Reinecke MG; Robinson WE Virology; 2004 Sep; 326(2):203-19. PubMed ID: 15302207 [TBL] [Abstract][Full Text] [Related]
32. Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters. Pluymers W; Neamati N; Pannecouque C; Fikkert V; Marchand C; Burke TR; Pommier Y; Schols D; De Clercq E; Debyser Z; Witvrouw M Mol Pharmacol; 2000 Sep; 58(3):641-8. PubMed ID: 10953059 [TBL] [Abstract][Full Text] [Related]
33. L-chicoric acid, an inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase, improves on the in vitro anti-HIV-1 effect of Zidovudine plus a protease inhibitor (AG1350). Robinson WE Antiviral Res; 1998 Aug; 39(2):101-11. PubMed ID: 9806487 [TBL] [Abstract][Full Text] [Related]
34. The integrase of the human immunodeficiency virus as a novel target for the antiviral therapy of AIDS. Witvrouw M; Debyser Z Verh K Acad Geneeskd Belg; 2003; 65(5):325-34. PubMed ID: 14671848 [TBL] [Abstract][Full Text] [Related]
35. Microbial Natural Product Alternariol 5-O-Methyl Ether Inhibits HIV-1 Integration by Blocking Nuclear Import of the Pre-Integration Complex. Ding J; Zhao J; Yang Z; Ma L; Mi Z; Wu Y; Guo J; Zhou J; Li X; Guo Y; Peng Z; Wei T; Yu H; Zhang L; Ge M; Cen S Viruses; 2017 May; 9(5):. PubMed ID: 28489061 [TBL] [Abstract][Full Text] [Related]
36. Novel inhibitors of HIV integrase: the discovery of potential anti-HIV therapeutic agents. Nair V Curr Pharm Des; 2003; 9(31):2553-65. PubMed ID: 14529542 [TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus type-1 integrase containing a glycine to serine mutation at position 140 is attenuated for catalysis and resistant to integrase inhibitors. King PJ; Lee DJ; Reinke RA; Victoria JG; Beale K; Robinson WE Virology; 2003 Feb; 306(1):147-61. PubMed ID: 12620807 [TBL] [Abstract][Full Text] [Related]
38. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches. Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161 [TBL] [Abstract][Full Text] [Related]
39. Modulation of HIV-1 integrase activity by single-stranded oligonucleotides and their conjugates with eosin. Korolev S; Knyazhanskaya E; Anisenko A; Tashlitskii V; Zatsepin TS; Gottikh M; Agapkina J Nucleosides Nucleotides Nucleic Acids; 2011; 30(7-8):651-66. PubMed ID: 21888554 [TBL] [Abstract][Full Text] [Related]
40. Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase. McDougall B; King PJ; Wu BW; Hostomsky Z; Reinecke MG; Robinson WE Antimicrob Agents Chemother; 1998 Jan; 42(1):140-6. PubMed ID: 9449274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]